Use of low-level laser therapy as monotherapy or concomitant therapy for male and female Androgenetic alopecia | Zendy

RalphM Trüeb | Zendy; Andréia Munck | Zendy; MariaFernanda Gavazzoni | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Use of low-level laser therapy as monotherapy or concomitant therapy for male and female Androgenetic alopecia

Author(s) -

RalphM Trüeb,

Andréia Munck,

MariaFernanda Gavazzoni

Publication year - 2014

Publication title -

international journal of trichology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.494

H-Index - 22

eISSN - 0974-9241

pISSN - 0974-7753

DOI - 10.4103/0974-7753.138584

Subject(s) - concomitant , finasteride , medicine , combination therapy , adverse effect , laser therapy , minoxidil , pharmacotherapy , urology , dermatology , laser , prostate , physics , cancer , optics

Androgenetic alopecia (AGA) is the most common form of hair loss in men and in women. Currently, minoxidil and finasteride are the treatments with the highest levels of medical evidence, but patients who exhibit intolerance or poor response to these treatments are in need of additional treatment modalities.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research